经口机器人手术治疗残留与复发口咽癌的IDEAL 2a期探索性研究
本研究采用IDEAL 2a框架探索经口机器人手术(TORS)在残留与复发口咽癌中的作用。26例评估患者中21例接受TORS,5例改行开放切除;42.6个月时估算总生存48.2%、局部控制76.6%、疾病特异性生存77.1%。结论认为TORS是残留与复发口咽癌的可行治疗选择。
要点
- TORS可作为残留与复发口咽癌的可行治疗选择
- 42.6个月估算总生存48.2%、局部控制76.6%、疾病特异生存77.1%
- TORS具整块切除、术中超声辅助、免下颌骨劈开植入游离皮瓣的优势
核心结论
- TORS是残留与复发口咽癌的有效治疗选择,肿瘤学结局与开放手术及经口激光显微手术相当。
研究设计与样本
- 采用IDEAL 2a框架的早期外科创新探索性研究;26例患者评估TORS,21例接受该手术,5例接受开放切除。
主要发现
- 26例评估者中21例接受TORS,5例接受开放切除(4例因解剖或肿瘤范围不适合,1例为患者选择)。
- 3例接受术中超声辅助机器人切除,3例接受机器人辅助游离皮瓣植入。
- 研究描述了针对舌根残留与复发口咽癌的TORS技术改良。
- 42.6个月时估算总生存48.2%、局部控制76.6%、疾病特异性生存77.1%。
关键数值与推荐
- 21/26例接受TORS;5例开放切除中4例因解剖或肿瘤范围不适合、1例为患者选择。
- 3例术中超声辅助机器人切除,3例机器人辅助游离皮瓣植入。
- 42.6个月估算总生存48.2%、局部控制76.6%、疾病特异性生存77.1%。
临床怎么用
- 对经选择的残留与复发口咽癌患者,可考虑TORS作为开放手术与经口激光显微手术之外的选项。
- 可利用术中超声辅助切除及机器人辅助游离皮瓣植入,避免下颌骨劈开。
局限性
- 为IDEAL 2a早期探索性研究,样本量小(26例评估、21例手术),结论需进一步评估验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to identify the role of transoral robotic surgery (TORS) in the management of residual and recurrent oropharyngeal cancer. METHODS: IDEAL (Idea, Development, Exploration, Assessment, Long-term Follow-up) 2a framework. RESULTS: Of 26 patients assessed for TORS, 21 underwent the procedure, 5 underwent open resection (4 due to unsuitable anatomy/tumor extent and 1 on the basis of patient choice). Three patients underwent intraoperative ultrasound-assisted robotic resection, and 3 received robotic-assisted free flap inset. A technical refinement for TORS of residual and recurrent oropharyngeal cancer of the tongue base is described. Actuarial plots showed estimated overall survival of 48.2%, local control of 76.6%, and disease-specific survival of 77.1% at 42.6 months. CONCLUSION: TORS is a valid management option for residual and recurrent oropharyngeal cancer. Oncologic outcomes are comparable to open surgery and transoral laser microsurgery, with the added advantages of en bloc resections, facility for intraoperative ultrasound imaging, and inset of free flaps without mandibular split.
引用
- Paleri V, Fox H, Coward S, et al. Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies. Head Neck. 2017. PMID: 29244229. doi:10.1002/hed.25032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。